Open access · US-GOV via ClinicalTrials.gov Clinical trial

Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations

Authors not listed

Mathew S. Maurer, MD · 2019

Mitochondrial dysfunction Human Randomized controlled trial

Abstract

In this study, the investigators recruited a cohort of elderly Black and Hispanic patients with heart failure to define the number of patients who have cardiac amyloidosis by utilizing highly sensitive heart imaging and blood tests. The investigators also explored differences in genetics and sex as they relate to heart failure disease progression in cardiac amyloidosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2019). Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations. <em>Mathew S. Maurer, MD</em>. https://clinicaltrials.gov/study/NCT03812172

Vancouver

Anonymous. Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations. Mathew S. Maurer, MD. 2019.

BibTeX

@misc{anon2019Screen, title = {Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations}, author = {Anonymous}, journal = {Mathew S. Maurer, MD}, year = {2019}, }